Delivery Order SPE2DB20D9331-SPE2DB24FL0Y6
Award Date 4/15/24
Potential Completion Date 5/6/24
Potential Value $249K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,614.78, is for the delivery of 3,750 units of the drug ASPARLAS (5 mL vials) with a completion date of May 17, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ml vials. The contract has a firm-fixed price of $148,084.30 and a period of performance ending on June 26, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,616.86 delivery order is for the supply of 3,750 units of the 5 mL vial of the drug ASPARLAS, with a performance period ending on June 4, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 milliliter vials. This firm fixed-price delivery order is expected to reach completion by August 29, 2025, and represents a continuation of the companies' ongoing pharmaceutical supply relationship. The award carries no set-aside designation, indicating that DMS...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $138,073.90, is for the delivery of 3,750 units of the pharmaceutical product ASPARLAS in 5 ML vials. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. This IDC,...
- The Defense Logistics Agency awarded a $148,084.30 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 17, 2025. The delivery order calls for 3,750 units of Asparlas (5 ML vials) with a completion date of August 7, 2025. This firm fixed-price contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The award...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $27,614.78 contract is to provide 3,750 units of the pharmaceutical product ASPARLAS (5 mL vials) with an ultimate completion date of April 10, 2024. DMS Pharmaceutical Group holds a $4,999,999 indefinite delivery vehicle (IDV) contract with DLA under the SPE2DB program to supply a broad range of pharmaceutical...
- This federal contract award, valued at $118,467.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 3,750 units of the drug ASPARLAS in 5 mL vials. The contract has an ultimate completion date of April 1, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $138,073.90 and an ultimate completion date of May 29, 2024. DMS Pharmaceutical Group will provide 3,750 units of the pharmaceutical product ASPARLAS (5 ML vial) to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery...
- This federal contract award, valued at $55,229.58, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order, is for the supply of 3,750 units of a 5 ml vial of the medication ASPARLAS. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...